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The delivery of certain living microorganisms in food has long been suggested as having positive health effects in humans.
This practice has extended into food animal production, with a variety of microorganisms being used; lactic acid bacteria, various
Bacillus species and the yeast Saccharomyces cerevisiae have been particularly used in the pig industry. The increased interest
in probiotics is essentially due to the problem of microbial resistance to antibiotics and following the ban of the use of antibiotics
in animal production, probiotics being considered an alternative means to reduce pathogen infection and improve animal health
especially around the time of weaning. However, there is still a need to clarify the probiotic effectiveness in pigs, and the
underlying mechanisms. When assessing the efficacy of probiotics one must consider the particular strain of organism being
used and the production stage of the pigs being treated. The reproducible delivery of probiotics in industrial pig production is
problematic as maintenance of viability is key to their beneficial activity, but difficult to achieve with commonly used feed
processing technologies. One specific context where probiotics organisms may be reliably delivered is in systems utilising
fermented liquid feeds. Liquid feed may be fermented by the activity of wild lactic acid bacteria or may be stimulated using
specific isolates as ‘starters’; the latter system has advantages in terms of reproducibility and speed of fermentation. The farm
context in which the organism is used is likely to be critical; the use of probiotics is more likely to result in measurable economic
gains in animals living in sub-optimal conditions rather than in those reared in the highest welfare and husbandry conditions.
The establishment of a beneficial lactic acid bacteria population at birth may lead to healthier animals, this may be most
effectively achieved by treating sows, which provide an amplification step and flood the neonatal pigs’ environment with
desirable bacterial strains. In contrast, it may be sufficient to provide a supportive, protective microbiota around the time
of weaning as this is a time of major crisis with instability and loss of certain bacterial populations.
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Implications
This review provides the scientific background to the use of
probiotics in the pig industry to control bacterial gut infection.
Given the European Union ban on the use of prophylactic
antibiotics, this approach could have a significant positive
effect upon the economic viability of pig producers.
Introduction
The concept of probiotics, defined as ‘live microorganisms
which, when administered in adequate amounts, confer a
health benefit on the host (FAO/WHO, 2001)’, was first noted
by Metchnikov in his book ‘The Prolongation of Life’ in 1908.
He ascribed the noted longevity of certain Bulgarian peasants
to their high consumption of milk products fermented with
lactic acid bacteria (probably Lactobacillus delbrueckii sub-
species bulgaricus). The mechanism by which this happened
was supposed to be via modification of the community of
bacteria present in the colon; Metchnikov postulated that many
human ills were due to the overgrowth of undesirable colonic
bacteria.
A large amount of work on the efficacy of probiotics in
human disease has been carried out (for recent reviews see
Marchesi and Shanahan, 2007; Doron et al., 2008; Parkes
et al., 2009; Collado et al., 2009; Lomax and Calder, 2009).
Certain aspects of this work can be applied to the pig, parti-
cularly mechanistic studies looking at the interaction of pro-
biotics with host mucosal surfaces or pathogenic bacteria
(Madsen et al., 2001; Roselli et al., 2007). However, this
‘human model’ does not give many insights into the efficacy of
probiotics in terms of production parameters in the pig industry.
In this review, we will describe key aspects of the biolo-
gical interactions between various mammals and probiotics- E-mail: Bev.Miller@bris.ac.uk
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with particular emphasis on possible underlying mechanisms.
We will then review the literature on the use of probiotics in
pigs, including information with respect to the most effective
time of application. We will also discuss the use of fermented
liquid feed in the pig industry as a means of delivering pro-
biotic organisms. The delivery of probiotics to pigs is proble-
matic due to the harsh processes used in feed processing and
the inherent fragility of bacteria; technological aspects of
delivery that may address these problems will be discussed.
Gut bacteria and health
Most of the health benefits ascribed to the administration of
probiotics are linked to modulation of either host or bacterial
factors in the gastrointestinal tract. It is thus appropriate to
spend some time here considering the significance of bac-
teria to the host’s well-being. The gastrointestinal tracts of
humans and pigs are colonised by a wide array of bacteria,
yeasts and viruses (Sears, 2005). In humans, the number of
bacterial cells outnumbers the cells composing the host’s
body by 10-fold. This bacterial component of the host, par-
ticularly the bacteria of the gut, may be seen as an extra,
indispensable organ, which contributes an array of gene
products not native to the host, such as a plethora of specific
glycosidases (Kim et al., 2007; Klaenhammer et al., 2008).
Animals raised in the absence of bacteria show profound
retardation in the developmental adult gut morphology and
immune function (Nanthakumar et al., 2003; Wagner, 2008).
The endogenous microbiota provides critical support to
the host in areas such as vitamin and co-factor production,
usage of otherwise indigestible feed ingredients, detox-
ification of food components, coating the gut with a benign
microbiota to physically exclude pathogens, production of
natural antibiotics and antifungals, maintainance of gut barrier
function and promotion of anti-inflammatory response (Madsen
et al., 2001; Hooper et al., 2002; Ouwehand et al., 2002; Roselli
et al., 2007). A novel role in regulating fat storage has been
recently ascribed to microbiota by recent studies, a promotion of
monosaccharides absorption from the gut resulting in induction
of de novo hepatic lipogenesis has been shown by comparing
germ-free mice with conventionalised mice (Ba¨ckhed et al.,
2004). Furthermore, an increased capacity to harvest energy
from the diet has been observed by comparing gut microbiota
of obese and lean mice (Turnbaugh et al., 2006).
Gut microbiota plays a critical role in ‘educating’ the
neonatal gut immune system to generate functional adult
systems for recognising pathogens and dealing with novel
food antigens (Calder et al., 2006; Williams et al., 2006;
Boirivant et al., 2008).
Early-life experience of the environment is critical in pro-
gramming, or ‘imprinting’ the range of microbial biotypes
which will accompany the host for their subsequent life
(Zoetendal et al., 2001; Favier et al., 2002). The similarity of
bacterial microbiota’s varies between individuals on the
basis of genetic relatedness and environmental experience
(Mueller et al., 2006). A complex microbiota (many different
biotypes) may confer advantages to the hosts by allowing
rapid adaptation to environmental changes (Marchesi and
Shanahan, 2007). The importance of early-life exposure on
subsequent development of a rich, diverse microbiota is shown
in studies comparing the microbiota of children normally
delivered and those delivered by caesarean section; the latter
children had markedly less complex microbiota (Gronlund
et al., 1999; Biasucci et al., 2008). Children born and raised in
relatively clean environments have been shown to have higher
rates of atopy in later life, possibly reflecting the importance of
bacterial diversity in the development of a competent, efficient
immune system, this connection between over-clean environ-
ments and subsequent immunological dysfunction is referred
to as ‘The Hygiene Hypothesis’ (Strachan, 1989).
However, although most studies indicate an association of gut
microbiota composition with atopic disease, the specific harmful
or protective microbes have not yet been identified (Penders
et al., 2007). Recent results have highlighted the need to enlarge
the concept of the hygiene hypothesis, and these aspects are
well discussed in a recent review by Isolauri et al. (2009).
According to these authors, three aspects should be considered
in the re-evaluation of the hygiene hypothesis: the importance of
gut microbiota composition in consolidation of healthy immune
responsiveness; the new knowledge of immunomodulatory and
suppressive immune responses extending the original ‘T helper
1/T helper 2’ paradigm; the role of host-microbe interaction
in the development of not only atopic disease but also of
other inflammatory diseases, including obesity.
It is unlikely that newborn pigs would be suffering from
a deficit of microbial complexity in their environment
under natural conditions. It is important to note that their
endogenous microbiota is largely established at this time
(Konstantinov et al., 2006; Thanantong et al., 2006). However,
it is possible that piglets born into regularly sterilised far-
rowing accommodation may acquire a substantially different
microbiota from the substrate than they would in an outdoor
farrowing situation. This has indeed been shown in recent
studies in pigs raised in different high v. low hygiene envir-
onments, which showed that such differences significantly
affect not only intestinal microbiota composition but also the
mucosal innate immune function in neonates, as well as in
adult animals (Mulder et al., 2009; Inman et al., 2010).
Increasingly, research is taking place to look at bacterial
‘imprinting’ in early life. In an ideal world, the piglet should pick
up a protective gut microbiota at birth which would improve
nutrient availability by providing vitamins, short chain fatty
acids or aminoacids (Cheeson, 1994; Metges, 2000; Resta,
2009), while protecting against environmentally acquired
pathogens by direct and indirect (stimulation of the host
immune system) means (Ouwehand et al., 2002; Bailey, 2009).
This may be the most important ‘window’ for establishing a
potentially beneficial bacterial community, in order to set up
life-long, stable associations between the host and microbe.
Do probiotics work? – an overview
Anecdotally, probiotics have been thought to be useful in
the treatment of numerous gastrointestinal disturbances in
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humans and farm animals (Calder et al., 2006; Lalle`s et al.,
2007; Marchesi and Shanahan, 2007; Collado et al., 2009;
Setia et al., 2009; Shanahan, 2009). Especially, earlier stu-
dies have often suffered from a lack of rigorous study design,
characterisation of probiotic strains, sufficient duration of
treatment or description of host microbiota. Where studies
have been carefully carried out, the commercial claims for
many probiotics are difficult to substantiate. However,
in humans, a number of gastrointestinal tract conditions
appear to be alleviated by treatment with various lactic acid
bacteria (LAB); for example, various types of inflammatory
bowel disease have been shown to respond well to treatment
with LAB (Mimura et al., 2004; Bibiloni et al., 2005). Similarly,
there appears to be some benefit in prophylactic and reactive
treatment with probiotics in traveller’s diarrhoea (usually
caused by enterotoxigenic E. coli ), rotaviral diarrhoea in
infants using L. rhamnosus GG and dirrhoea related to anti-
biotic use (Sazawal et al., 2006; Henker et al., 2008).
Historically, the situation in pigs is complicated by the
fact that until recently, the industry routinely used antibiotic
compounds as growth promoters. Although generally used at
sub-therapeutic, these compounds almost certainly reduced
intestinal pathogen loads. The most vulnerable times in the pig’s
life are immediately after birth and the 2-week period post-
weaning. The legislative withdrawal of in-feed antimicrobials
was expected to lead to increased mortality or decreased
hardiness in these life stages. In fact, the situation seems to be
more complex than this intuitive picture. In Sweden, the pig
industry was, indeed, hit by the reduction in antimicrobial cover.
However, the institution of relatively inexpensive husbandry
modifications has allowed the industry to return to levels
of productivity similar to those seen before the ban (Wierup,
2001). In addition, numerous institution-based experiments (as
opposed to real farm conditions) have shown that in-feed
antimicrobials are at their most effective in animals being raised
under sub-optimal conditions (Dritz et al., 2002). Where high
welfare, high health status animals are used, as in agricultural
research centres, the gains produced by in-feed antimicrobials
are marginal, at best (Zeyner and Boldt, 2006). These findings
may inform subsequent research into the efficacy of probiotics.
Although many studies looking at the role of probiotics in
pigs have been published (Bomba et al., 2002; Konstantinov
et al., 2008; Bird et al., 2009; Lessard et al., 2009; Martin
et al., 2009; Pieper et al., 2009; Szabo et al., 2009; Wang et al.,
2009), it is very difficult to perform any meaningful metanalysis
as the organisms, strains, doses and duration of the experi-
ments are so varied, not to mention the confusing effects
of husbandry, environment and genotype on the immune sys-
tem and microbiota of the animals being studied. Certainly,
it would be desirable to compare different probiotics and
to follow the piglets through the weaning phase in well-
controlled large-scale experiments.
To conclude, it seems unequivocal that certain bacterial
supplements, under the appropriate conditions, can have a
positive effect on the physiology of recipients. The difficulty lies
in exact determination of the appropriate organism, dose of
viable organisms and the life cycle stage of the recipient animal.
How do probiotics work?
We will limit the discussion here to the interactions occurring in
the intestine. Probiotics might be expected to act either directly
on the host, strengthening anti-pathogen defences, or the
observed benefits may reflect the ability of a particular probiotic
organism to adversely affect the survival of deleterious bacteria.
Probiotics may also influence the availability of feedstuffs,
enhancing the supply of some nutrients. Most bacteria used as
probiotics are common intestinal bacteria such as species of
Bacillus, Lactobacillus and Bifidobacterium. The roles of such
commensal bacteria have received much attention in recent
years; in particular, the ability to mono-colonise gnotobiotic
animals has allowed us to see how important the bacteria of
the gut are to its development (McFall-Ngai, 2002).
Probiotic actions on host physiology
Carriage of a large number of bacteria in the gut of a pig
(and all other vertebrates) obviously has a cost in terms
of energy. This cost may either be assimilation of nutrients
by bacteria, thus reducing the availability of dietary compo-
nents to the animal, or in terms of mounting an immune
response to the bacteria. The effects of subclinical infections
with pathogens are likely to be important with respect
to production parameters, as energy spent fighting non-
beneficial bacteria is energy lost to the animal, and farmer, in
terms of growth and efficient feed conversion. It is in these
compromised, but not overtly ill, animals that probiotics or
other interventions to reduce the load of damaging bacteria
may be most useful. To this end, it is interesting to note that
a recent study showed a positive effect of probiotic treat-
ment of E. coli F4 infected weaned piglets with L. sobrius not
only on pathogen levels, but also on average daily weight
gain (Konstantinov et al., 2008).
Cheeson (1994) identified a number of factors that may
be expected to change with alterations to the intestinal
bacterial microbiota in pigs, including an increase in the
proportion of the amino acid pool that is available to other
tissues (e.g. skeletal muscle), a reduction of endogenous
nitrogen losses and a corresponding increase in apparent
nitrogen digestibility and absorption. In fact, metabolic
requirement is met not only by the diet but also by amino
acids provided by the gastrointestinal microbiota, and from
1% to 20% of plasma, urinary and body lysine of the host
has been calculated to derive from intestinal microbial
sources (Metges, 2000).
Probiotics may also affect the absorption/secretion activity
of intestine in pigs A slightly higher L-glutamine transport
and increased ion secretion was observed in Bacillus cereus
or Enterococcus faecium treated pigs, at 28 days of age
(Lodemann et al., 2006; Lodemann et al., 2008). In a study
carried out in pigs to screen lactic acid bacteria producing
active dietary enzymes, such as amylase, lipase, phytase and
protease, Lactobacillus sp. PSC101 was selected as a strong
probiotic candidate due to its resistance to both acid and bile
and production of dietary enzymes promoting animal growth
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(Kim et al., 2007). A previous study in germ-free mice using
the organism Bacteroides thetaiotamicron has shown that
introduction of the bacteria is critical for induction of critical
glycolytic enzymes in the enterocytes (Bry et al., 1996).
Considering all these data, it follows that in immature ani-
mals there is a scope for enhancing positive interactions
between host and microorganisms in the gut. It has now also
been generally accepted that gut microbiota has to be con-
sidered a pivotal factor in shaping the host’s metabolism,
where differences in microbiota composition have strong
effects on overall energy yield from the diet, and thus body
weight (for a recent review, see (Vrieze et al., 2010)). In the
strict definition of the word ‘probiotic’, pre-emptive admin-
istration of bacterial strains capable of stimulating the
widest possible range of food substrate degrading enzymes
in the young pigs’ gut would be desirable as a means of
maximising the efficiency of food assimilation.
In ex vivo or in vitro models, it has been shown that
incubation of intestinal cells with various Lactobacilli species
protect against pathogen-induced disruption of membrane
barrier. This appears to be a multi-factorial process involving
both induction of mucus secretion from goblet cells (Mack
et al., 1999; Caballero-Franco et al., 2007) and maintenance
of the tight cell junctions between cells (Madsen et al., 2001;
Roselli et al., 2007; Putaala et al., 2008). This function may
be most important in counteracting the effects of pathogens,
which often exert gastrointestinal effects by weakening
the junctions between cells allowing for translocation of the
pathogens and activation of inflammatory signals or estab-
lishment of local inflammatory lesions. Studies on protective
activity of probiotics on membrane barrier of pigs are rare.
Other than the described mechanisms, probiotics may pro-
vide defence to the cells through induction of anti-inflammatory
cytokines, and reduction of pro-inflammatory cytokines, from
enterocytes and intestinal immune cells recruited to sites of
inflammation by probiotics (O’Hara et al., 2006; Walsh et al.,
2008; Wang et al., 2009). Cytokines are also involved in the
maintainance of barrier integrity induced by probiotics (Roselli
et al., 2007). However, the exact mechanisms of probiotic
protection are still largely unknown.
One system that is an attractive target by which probiotics
may exercise strong influence is the innate immune system.
The intestine has a range of non-specific anti-bacterial
weapons that are constitutively produced by enterocytes or
specialist cell types. Of particular interest are the defensins,
pore-forming antimicrobial peptides produced by Paneth
cells and other cells included neutrophils and macrophages;
these molecules act as antimicrobials by directly inhibiting
pathogen growth, as well as potentiating branches of the
innate, humoral and cell-mediated immune system (Linde
et al., 2008). Defensin induction seems to be a common and
important mechanism of probiotic treatment (Mondel et al.,
2009). In vitro work has shown that a commonly used pro-
biotics cocktail VSL#3, containing four Lactobacillus species,
three Bifidobacterium species and one Streptococcus is a
powerful inducer of b-defensin synthesis. The mechanism
appears to be via nuclear factor (NF)-kB and activator protein-1
(AP1) intermediates, which is interesting as probiotics are
intuitively regarded as being anti-inflammatory (Schlee et al.,
2008). In a recent in vivo study, cells of L. plantarum WCFS1
were given to healthy volunteers, and their effect on duodenal
gene expression was investigated, showing cellular pathways
and mucosal gene expression patterns correlating with the
establishment of immune tolerance in healthy adults (van
Baarlen et al., 2009).
The toll-like receptors (TLR) are regarded as one of the
gut’s primary means of detecting and initiating responses
to microbial molecular markers. Ligation of TLR initiates a
signalling cascade that results in the activation of the tran-
scription factor NF-kB and subsequent up-regulation of
co-stimulatory molecules as well as inflammatory cytokines
and chemokines (Kumar et al., 2009). Thirteen mammalian
TLRs have been identified so far, and they are expressed in
diverse cell types including gut epithelial cells, B cells, mast
cells, dendritic cell, macrophages, neutrophils and T reg-
ulatory (Treg) cells (Sutmuller et al., 2006), the ubiquitous
nature of TLR mRNA expression in pigs is also emerging
(Shimosato et al., 2005; Tohno et al., 2005; Thomas et al.,
2006). There is currently much research focussed on how
these sensors are able to distinguish between commensal
and pathogenic bacteria, which bear the same microbial
patterns, in such a way that the appropriate ‘danger’ signals
can be generated to pathogens but not inappropriately to
benign organisms. Evidence that TLR signalling, especially
TLR9, is implicated in the protective effects of probiotics on
various models of colitis has been reported in recent studies
(Rachmilewitz et al., 2004). B. longum and L. plantarum
were shown to improve colitis by inhibiting inflammatory
cytokine expression via TLR-4-linked NF-kB activation and
by inhibiting intestinal bacterial glycosaminoglycan degra-
dation (Lee et al., 2009). Studies on pigs reported that
suplementation with B. animalis affected the expression of
TLR-2 in the lymph nodes when fructo-oligosaccharides were
added to the diet (Trevisi et al., 2008). In addition, tumour
necrosis factor-a was positively correlated with TLR-2 and
negatively correlated with bifidobacteria DNA. A recent
study highlighted a diverse innate and adaptive immune
responses induced by L. acidophilus and L. reuteri v. rotavirus
infection in gnotobiotic pigs (Wen et al., 2009).
The ability of probiotics to influence the adaptive immune
system of pigs has been described in several studies. There
have been a number of studies looking at the effects of
probiotics on serum and faecal immunoglobulin concentra-
tions. A recent study has found that E. faecium treatment
enhanced the course of infection in weaning piglets chal-
lenged with Salmonella serovar Typhimurium, however, the
probiotic treatment resulted in greater production of specific
antibodies against Salmonella (Szabo et al., 2009).
In a study, in which pregnant sows were given either
B. cereus or E. faecium significant decreases were seen in
the serum IgG levels of the piglets post-weaning, perhaps
reflecting the increased stability of the gut wall, with a
concomitant reduction in translocation of bacteria from the
gut into the systemic circulation (Scharek et al., 2007).
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Interestingly, increased levels of faecal IgA were seen in the
group given B. cereus compared to the E. faecium group and
the other controls.
Similar increases in faecal IgA, following probiotic treat-
ment, has been observed in human infants (Fukushima et al.,
1998; Rinne et al., 2005). These studies have been aimed at
using probiotics to ameliorate the symptoms of food allergy.
It is postulated that mucosal IgA may ‘mop up’ potentially
harmful food antigens preventing them from causing
inflammatory consequences leading to pathology. It is worth
noting in all cases mentioned that the specificity of the IgA
molecules has not been determined. It should be noted also
that a role for probiotics in accelerating or amplifying the
process of immunological tolerance to food antigens has
been proposed (Savilahti et al., 2008).
The effect of probiotics on immune cells is less clear. The
distribution of intestinal immune cells (granulocytes, mast
cells, CD41, CD81, CD251, IgA1 lymphocytes) and the
mucosal expression of cytokines (IFN-g, TNF-a, TGF-b, IL-10)
of young pigs were not changed by E. coli Nissle administration
(Duncker et al., 2006). On the other hand, L. acidophilus and
L. reuteri were able to down-regulate the rotavirus induced
activation/recruitment of monocytes/macrophages and CD14
expression in the intestine of neonatal gnotobiotic pigs,
thereby limiting inflammation (Zhang et al., 2008). More
intriguing was the response to L. fermentum in weaned
pigs, that induced an increase in the pro-inflammatory
cytokines IFN-g and TNF-a, in the ileum, and an increase in
the percentage of CD41 lymphocyte subset in blood (Wang
et al., 2009).
Action of probiotics on other bacteria
Bacteria form complex associations within the ecosystem of
the gut. The different organisms modulate their environment
in ways that facilitate the growth of certain microbes while
inhibiting the growth of others. The aim of therapeutic pro-
biotics is to facilitate the growth of one or more organisms
which inhibit the growth of potentially deleterious organ-
isms (Servin, 2004).
The most closely studied group of organisms in this
respect is the Lactobacillus genus. The reduction in pH
mentioned earlier, a consequence of their preferred fer-
mentative metabolism, is recognised as important in redu-
cing the growth rates of potential pathogens, particularly
enterobacteria such as Salmonella and E. coli. It is worth
noting that unionised lactic acid is an effective, non-specific
permeabiliser of Gram-negative cell membranes (Alakomi
et al., 2000). More specifically, lactobacilli in general elabo-
rate a range of peptide-based molecules generically referred
to as ‘bacteriocins’ (Cotter et al., 2005). Colicins are gen-
erally most effective against closely related, Gram-positive
organisms. However, there have been numerous reports of
lactobacilli and bifidobacteria inhibiting the growth of Gram-
negative bacteria by a mechanism(s) that do not involve pH
reduction or volatile fatty acid production (e.g. Coconnier-
Polter et al., 2005; Fayol-Messaoudi et al., 2005).
In addition to actively inhibiting the growth of potential
pathogens a general mode of action for probiotics is their
ability to competitively exclude access of pathogens to the
luminal surface of the gut epithelial cells. This may be due to
direct competition for specific receptors or by steric hindrance
where the bulk of the probiotic organisms on the cell surface
prevent access of pathogens to their cognate receptors (e.g. Jin
and Zhao, 2000; Roselli et al., 2007).
Fermented liquid feeds
Since lactobacilli have direct and indirect actions against
spoilage and pathogenic bacteria, as well as potential
health-promoting effects, they are attractive candidates as
additives to feed stuffs. Fermentation of liquid pig feed by
LABs occurs naturally on farms but the organisms respon-
sible and the extent of the fermentation is uncontrolled. The
literature on the efficacy of fermented liquid feeds (FLF)
indicates that they are generally positive in terms of reducing
pathogen load in feed and environment (van der Wolf et al.,
2001; van Winsen et al., 2002), improving growth/produc-
tion parameters (Kyriakis et al., 1999), and reducing carriage
of pathogens in pigs fed on FLF compared to conventionally
fed animals (Boesen et al., 2004). However, there is con-
sistent production of research studies showing that the
gains associated with feeding FLF are marginal, at best
(e.g. Lawlor et al., 2002; Canibe and Jensen, 2003; Canibe
et al., 2007). The lack of consistency between experimental
designs make direct comparisons, and logical interpretation,
of the many studies difficult (Plumed-Ferrer and von Wright,
2009). The primary difficulty is that the wide range of
organisms used to cause fermentation obviously do not all
have the same fermentation characteristics; add to this the
different feed substrates (whole feed or just cereal compo-
nents) and different starter concentration, duration of fer-
mentation and temperature; it becomes evident that a clear
picture would be a surprise rather than an expectation!
One of the repeated claims against the use of FLF is that
there is a reduction in the available lysine (a growth limiting
nutrient for pigs) in fermented compared to unfermented
feed (P. Brookes, personal communication). It appears that
early in the course of natural fermentations Enterobacter-
iaceae grow and utilise significant amounts of lysine before
the LABs can produce sufficient lactate (with a subsequent
drop in pH). Where LABs are inoculated in sterile feed there
is only a very slight drop in available lysine supporting
the contention that the enterobacterial bloom, rather than
LAB growth, is responsible for the lysine depletion (Niven
et al., 2006). This highlights the need for controlled, highly
reproducible fermentations where relatively large quantities
of highly active LAB cultures are used to initiate fermenta-
tions (Plumed-Ferrer and von Wright, 2009). In a well-
controlled fermentations LAB numbers can reach 1010 cfu/ml.
The criticism of many clinical trials of probiotics in humans
is that insufficient numbers of viable organisms are deliv-
ered; this would not be the case in pigs eating exclusively
fermented feed.
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In field experiments the effect of an L. plantarum fermented
diet on Salmonella carriage and shedding was equivocal,
although the total Enterobacteriaceae population was reduced
(van Winsen et al., 2002). Under more controlled laboratory
conditions we have shown a clear reduction in Salmonella
carriage in FLF-fed animals where a different strain of
L. plantarum was employed and lactate levels of 200 to
250 mM and a pH of,4 were consistently maintained (Kenny
et al., awaiting publication) with no difference in food con-
version ratio between the FLF and control groups. On the farm
fermentations, using a defined medium have shown that a
stable, high lactate, low yeast fermentation can be achieved
using an L. plantarum starter (Plumed-Ferrer et al., 2005).
In conclusion, the assessment of the efficacy of FLF is even
more problematic than that for probiotics in general. The careful
choice of fermentation organism, feed substrate and pig life-
cycle stage, coupled with a relatively complex and expensive
agrotechnical fermentation and delivery system are necessary
for this method of probiotic delivery to achieve its potential.
Direct fed microbials
The challenge of delivering viable beneficial microbes to swine
(and other target species) has exercised the pharmaceutical
and agricultural feed industry for many years. The human
probiotic field has been embarrassed on several occasions by
expose´s clearly demonstrating that the quantity, type and
quality of organisms in commercial preparations was wildly
different to that described on the packaging (Huys et al., 2006;
Marcobal et al., 2008). For optimal use in a farm setting, any
microbial feed additives should be cost-effective, stable to
moisture (or portion packed) and temperature. These criteria
are difficult to meet reliably for most bacteria, however, bifi-
dobacteria in particular have short shelf lives if not maintained
carefully. Nevertheless, a number of commercial preparations
are available to pig farmers and have been tested relatively
rigorously. The most critical periods in which the probiotics
have been tested are the period around farrowing, the first
week of life and the post-weaning period.
In biological terms, the easiest microbes to manipulate are
those that produce spores; spores are extremely robust and
stable yet non-replicating under normal storage conditions.
In addition, many Bacillus species produce antibiotics called
bacitracins, which are effective against many Gram-positive
organisms. Several spore-forming species of the genus
Bacillus (B. subtilis, B. licheniformis and B. cereus var toyoi)
have been used in the pig industry. Interestingly, these
organisms are not usually part of the indigenous porcine gut
microbiota; they are however common soil bacteria, which
are likely to be transient passengers through the guts of
most outdoor reared pigs.
Treatment of sows and their litters with feed supplemented
with B. cereus var Toyoi reduced carriage of pathogenic E. coli
strains and resulted in altered absolute numbers and distribu-
tions of immune cells in the piglets (Scharek et al., 2007).
Piglets from the group given the microbial supplement had a
reduced incidence of diarrhoea and liquid faeces; they also
had higher average daily gains and feed : gain ratios (Taras
et al., 2005). Another study describes a large-scale study
(nearly 22 000 piglets) comparing the production character-
istics when sows were fed the same diet with either a pro-
prietary mix of B. licheniformis and B. subtilis or a standard
mixture of anti-microbial growth promoters (Kritas and
Morrison, 2005). The cost of producing each kilogram of
pork and all other production parameters were statistically
the same showing that the probiotic supplementation was
effective at replacing the non-specific chemical inhibition
traditionally used in the pig industry.
It is becoming clear that the gut microbiota of animals,
including humans, is critically determined at the very earliest
stages after birth (‘microbial imprinting’; Favier et al., 2002;
Konstantinov et al., 2006). Organisms that are abundant in
the piglet’s environment at this time have a high chance of
forming a permanent association with the piglet’s intestinal
mucosa (true ‘colonisation’). It may transpire that this is
the most efficient time to deliver probiotics to ensure the
establishment of life-long health benefits and to produce a
robust microbiota, resistant to adverse ecological shifts at
times like weaning. The most efficient way to deliver pro-
biotics to piglets may be to dose sows before and during
farrowing so that she, and her environment, is saturated
with desirable organisms in a form whereby the piglet can
acquire them as part of its natural development.
Conclusion
The use of live bacterial cultures in the pig industry, whether to
improve resistance to specific pathogens or to non-specifically
enhance pig health, is likely to continue and expand as eco-
nomic pressures to improve production parameters and public
resistance to the use of ‘chemicals’ in meat production
increase. The general public is familiar with the concept of
probiotics (‘friendly bacteria’) and would welcome their use in
sustainable animal production strategies.
There is an increasing body of well-designed in vitro and
in vivo studies, which suggest that certain microbial supple-
ments are useful in protecting particularly young pigs from
intestinal infections around weaning. This period, and other
stressful mixing events during their lives, is probably important
as the point at which pigs pick up important zoonotic patho-
gens, such as S. enterica, but also Streptococcus suis (Su et al.,
2008). It is likely that appropriate probiotic treatments: whether
as direct fed microbials or fermented liquid feed will be useful in
reducing the burden of pig pathogens.
The challenge before the feed additive industry is to
identify organisms, which reliably enhance pig health, at a
defined stage in the production process, and to formulate
the viable organisms in a way that maintains their viability
in the hostile farm environment. The use of single types of
bacteria in the pig industry is likely to be superseded by
logically constructed mixtures of different organisms. Mixtures
of organisms are already available commercially, but detailed
comparisons of these mixtures with other treatments are
difficult to find.
Probiotics, have they a role in the pig industry?
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